These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25403901)

  • 21. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.
    Leppert K; Bisordi K; Nieto J; Maloney K; Guan Y; Dixon S; Egense A
    J Genet Couns; 2018 Dec; 27(6):1328-1340. PubMed ID: 29687313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
    Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
    Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary findings: How did we get here, and where are we going?
    Ormond KE; O'Daniel JM; Kalia SS
    J Genet Couns; 2019 Apr; 28(2):326-333. PubMed ID: 30821867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
    Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
    Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
    Evans BJ
    Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting.
    Downing NR; Williams JK; Daack-Hirsch S; Driessnack M; Simon CM
    Patient Educ Couns; 2013 Jan; 90(1):133-8. PubMed ID: 23068909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical considerations in the clinical application of whole-exome sequencing.
    Shashi V; McConkie-Rosell A; Schoch K; Kasturi V; Rehder C; Jiang YH; Goldstein DB; McDonald MT
    Clin Genet; 2016 Feb; 89(2):173-81. PubMed ID: 25678066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current controversies in prenatal diagnosis 2: The 59 genes ACMG recommends reporting as secondary findings when sequencing postnatally should be reported when detected on fetal (and parental) sequencing.
    Amor DJ; Chitty LS; Van den Veyver IB
    Prenat Diagn; 2020 Dec; 40(12):1508-1514. PubMed ID: 32091628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
    Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS
    Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical exome performance for reporting secondary genetic findings.
    Park JY; Clark P; Londin E; Sponziello M; Kricka LJ; Fortina P
    Clin Chem; 2015 Jan; 61(1):213-20. PubMed ID: 25414276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic Testing: a Genetic Counselor's Personal Reflection on Three Years of Consenting and Testing.
    Wynn J
    J Genet Couns; 2016 Aug; 25(4):691-7. PubMed ID: 26242468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic counselors and congenital heart disease: Clinical roles, genetic testing practices, and perceived genetic testing utility.
    Fitzgerald-Butt SM; Schartman AF; Schmit K; Ison HE; Helm BM
    J Genet Couns; 2024 Oct; 33(5):1004-1014. PubMed ID: 37872860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies.
    Niemiec E; Borry P; Pinxten W; Howard HC
    Hum Mutat; 2016 Dec; 37(12):1248-1256. PubMed ID: 27647801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes.
    Lindor NM; Schahl KA; Johnson KJ; Hunt KS; Mensink KA; Wieben ED; Klee E; Black JL; Highsmith WE; Thibodeau SN; Ferber MJ; Aypar U; Ji Y; Graham RP; Fiksdal AS; Sarangi V; Ormond KE; Riegert-Johnson DL; McAllister TM; Farrugia G; McCormick JB
    Mayo Clin Proc; 2015 Oct; 90(10):1327-37. PubMed ID: 26434960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Counseling Close to Home: Genetic Counselors' Experiences with their own Family Members.
    Rust L; Adamsheck H; Reiser CA; Petty EM
    J Genet Couns; 2018 Feb; 27(1):225-240. PubMed ID: 28815348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
    Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
    J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience.
    Lawrence L; Sincan M; Markello T; Adams DR; Gill F; Godfrey R; Golas G; Groden C; Landis D; Nehrebecky M; Park G; Soldatos A; Tifft C; Toro C; Wahl C; Wolfe L; Gahl WA; Boerkoel CF
    Genet Med; 2014 Oct; 16(10):741-50. PubMed ID: 24784157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?
    Jamuar SS; Kuan JL; Brett M; Tiang Z; Tan WL; Lim JY; Liew WK; Javed A; Liew WK; Law HY; Tan ES; Lai A; Ng I; Teo YY; Venkatesh B; Reversade B; Tan EC; Foo R
    EBioMedicine; 2016 Mar; 5():211-6. PubMed ID: 27077130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes Toward Discussing Approved and Investigational Treatments for Cystic Fibrosis in Prenatal Genetic Counseling Practice.
    Elsas CR; Schwind EL; Hercher L; Smith MJ; Young KG
    J Genet Couns; 2017 Feb; 26(1):63-71. PubMed ID: 27277131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.